Faculty profile

Alejandro Berlin

ResearcherRadiation Oncology/Medical PhysicsUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Alejandro Berlin

Researcher

Radiation Oncology/Medical Physics

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
109 publications in the last five years, latest in 2026.
Senior (last) author on 12 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

208

Publications

860

Citations

h-index

111

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Artificial Intelligence Automation Decision Support Image Segmentation Machine Learning Medical Physics Radiation Oncology Radiation Therapy

Latest papers

Transition from Oncologist- to Therapist-Led MRI-Guided Ultra-Hypofractionated Adaptive Prostate Radiation Therapy: Evaluation of Early Clinical Outcomes.
Current oncology (Toronto, Ont.) · 2026
Real-Time Magnetic Resonance Imaging Guidance to Enable Brachytherapy: A Case Series.
Practical radiation oncology · 2026
Stereotactic Body Radiation Therapy for Renal Tumors: A Prospective Phase 2 Clinical Trial.
International journal of radiation oncology, biology, physics · 2026

All 208 publications

Latest funding

Unlocking the Role of RNA Modifications in Prostate Cancer
CIHR · 2026 · Co-investigator
$1,147,500
Improving Access and Wellbeing of Patients with Lung Cancer: A Randomized Controlled Trial of a Lay Navigation Program
CIHR · 2025 · Co-investigator
$753,526
Synergistic Radiosensitization of Hypoxic Pancreatic Adenocarcinoma using Gd-Texaphyrin Oxygen-Loaded Nanodroplets
CIHR · 2023 · Co-investigator
$994,500

All 11 grants and awards

From the 150 most recent of 208 publications.

Transition from Oncologist- to Therapist-Led MRI-Guided Ultra-Hypofractionated Adaptive Prostate Radiation Therapy: Evaluation of Early Clinical Outcomes.

Moreira A, Rosewall T, Dang J, Kim A, Santiago AT, Mesci A, Gutierrez E, Bayley A, McPartlin A, Glicksman RM, Berlin A, Winter J, Li W, Chung P

Current oncology (Toronto, Ont.)2026

DOI: 10.3390/curroncol33070398 PMID: 42505200

Real-Time Magnetic Resonance Imaging Guidance to Enable Brachytherapy: A Case Series.

Mathew JM, Weersink R, Berlin A, Gutierrez Valencia E, Rink A, Serban M, Johny C, Malik N, Patel A, Chan K, Chung PW, Glicksman RM

Practical radiation oncology2026

DOI: 10.1016/j.prro.2025.12.009 PMID: 41485538

Stereotactic Body Radiation Therapy for Renal Tumors: A Prospective Phase 2 Clinical Trial.

Glicksman RM, Winter J, McPartlin A, Santiago AT, Wang K, Bernstein J, Dang J, Tsui G, Chung P, Mesci A, Gutierrez Valencia E, Raman S, Berlin A, Catton C, Bayley A, Warde P, Krishna S, Finelli A, Hamilton RJ, Pace KT, Kitchlu A, Helou J

International journal of radiation oncology, biology, physics2026

DOI: 10.1016/j.ijrobp.2025.11.005 PMID: 41290048

Genomic Predictors of Response to Metastasis-directed Therapy With or Without Androgen Deprivation Therapy.

Sutera P, Van der Eecken K, Song Y, Shetty AC, Davicioni E, Proudfoot JA, Hakansson A, English K, Wang J, Guler OC, Bazyar S, Verbeke S, Van Dorpe J, Fonteyne V, De Laere B, Hathout L, Ennis R, Jabbour SK, Saraiya B, Stephenson R, Mayer T, Mishra M, Rana Z, Molitoris J, Kiess A, Song DY, DeWeese T, Pienta KJ, Tran PT, Berlin A, Onal C, Ost P, Deek MP

European urology oncology2026

DOI: 10.1016/j.euo.2025.07.007 PMID: 40976747

Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate Cancer.

Roy S, Sun Y, Eastham JA, Gleave M, Wallis CJD, Beltran HA, Kishan AU, Jia AY, Zaorsky NG, Nagar H, Garcia JA, Small EJ, Nguyen P, Attard G, McKay RR, Sartor O, Berlin A, Rosenthal SA, Halabi S, Vince R, Ponsky L, Morgan SC, Hannan R, Raben A, Roach M, Michalski JM, Morris MJ, Sandler HM, Spratt DE

European urology oncology2026

DOI: 10.1016/j.euo.2025.06.009 PMID: 40683825

Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer.

Singhal U, Jiang R, Proudfoot JA, Chase E, Suresh K, Davicioni E, Borza T, Zelefsky MJ, Davis BJ, Stish BJ, Karnes RJ, Freedland SJ, Terris MK, Aronson WJ, Cooperberg MR, Moraes FY, Berlin A, Deville C, Zaorsky NG, Roy S, Jia AY, Shoag JE, Jackson WC, Spratt DE, Schipper M, Morgan TM, Dess RT

Prostate cancer and prostatic diseases2026

DOI: 10.1038/s41391-025-01062-8 PMID: 41366130

Downregulation of ANPEP Is Associated with Aggressive Prostate Cancer and Poor Disease-specific Outcomes.

Putney RM, Trivedi P, Awasthi S, Serna A, Dhillon J, Sweeney CJ, Jeffrey Karnes R, Cooperberg MR, Berlin A, Nguyen PL, Spratt DE, Davicioni E, Proudfoot J, Ryu M, Katende E, Park JY, Rebbeck TR, El-Kenawi A, Yamoah K

European urology open science2026

DOI: 10.1016/j.euros.2025.12.011 PMID: 41536952

Initial Experience with MR-Guided or CT-Guided Stereotactic Body Radiotherapy for Prostate Cancer.

Barcelona MVN, Sanmamed Salgado N, Valencia EG, Berlin A, Glicksman R, Catton C, McPartlin A, Winter JD, Dang J, Kong V, Deng Y, Chung P

Current oncology (Toronto, Ont.)2026

DOI: 10.3390/curroncol33090504 PMID: 42782851

Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomes.

Mathew JM, Bacon H, Winter J, Bernstein J, Liu ZA, Kong V, Dang J, Wang K, Chung P, Bayley A, Berlin A, Catton C, Gutierrez E, Mesci A, McPartlin A, Raman S, Alibhai S, Taylor E, Warde P, Glicksman RM

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2026

DOI: 10.1016/j.radonc.2026.111614 PMID: 42177994

A practical framework for operationalising responsible and equitable artificial intelligence in health care: tackling bias, inequity, and implementation challenges

Welch ML, Grant B, Deutschman C, McElcheran C, Badzynski A, Bell JAH, Hope A, Grant RC, Truong T, Lane K

The Lancet: Digital Health202615 citations

DOI: 10.1016/j.landig.2025.100957

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2022

Subject: Prospective PhD student: Artificial Intelligence Dear Professor Berlin, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Transition from Oncologist- to Therapist-Led MRI-Guided Ultra-Hypofractionated Adaptive Prostate Radiation Therapy: Evaluation of Early Clinical Outcomes." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Clinical Deployment of an End-to-End Artificial Intelligence (AI)-only Radiotherapy Treatment Planning and Decision Support Workflow" (2022), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Alejandro Berlin

Research

Latest papers

Latest funding

Transition from Oncologist- to Therapist-Led MRI-Guided Ultra-Hypofractionated Adaptive Prostate Radiation Therapy: Evaluation of Early Clinical Outcomes.

Real-Time Magnetic Resonance Imaging Guidance to Enable Brachytherapy: A Case Series.

Stereotactic Body Radiation Therapy for Renal Tumors: A Prospective Phase 2 Clinical Trial.

Genomic Predictors of Response to Metastasis-directed Therapy With or Without Androgen Deprivation Therapy.

Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate Cancer.

Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer.

Downregulation of ANPEP Is Associated with Aggressive Prostate Cancer and Poor Disease-specific Outcomes.

Initial Experience with MR-Guided or CT-Guided Stereotactic Body Radiotherapy for Prostate Cancer.

Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomes.

A practical framework for operationalising responsible and equitable artificial intelligence in health care: tackling bias, inequity, and implementation challenges

Frequent collaborators

Antonio Finelli

Nathan Perlis

Neil Fleshner

Gelareh Zadeh

Mark Bernstein

Patrick Veit-Haibach

Alexandra Rink

Mary Gospodarowicz

Danielle Rodin

Lisa Avery

Andrew Loblaw

Robert Weersink

Shabbir Alibhai

Alexandre Zlotta

Jenna Sykes

Catherine Coolens

Glenn Bauman

Janet Papadakos

Joseph Cafazzo

Tony Lam

Olli Saarela

Melanie Powis

Michael Yan

Sharon McGee

Marianne Koritzinsky

Quynh Pham

Srikala Sridhar

David Wiljer

Girish Kulkarni

Robin Urquhart

Mathieu Lupien

Jonathan Sussman

Ambreen Sayani

Stephanie Lheureux

Chris McIntosh

Gerard Morton

Eric Vigneault

David Hodgson

Simron Singh

Jeremy Petch